National Cancer Institute Smoking Cessation at Lung Examination Trials Brief Report: Baseline Characteristics and Comparison With the U.S. General Population of Lung Cancer Screening–Eligible Patients

National Cancer Institute Smoking Cessation at Lung Examination Trials Brief Report: Baseline Characteristics and Comparison With the U.S. General Population of Lung Cancer Screening–Eligible Patients

Introduction: The National Cancer Institute Smoking Cessation at Lung Examination (SCALE) Collaboration includes eight clinical trials testing smoking cessation interventions delivered with lung cancer screening (LCS). This investigation compared pooled participant baseline demographic and smoking c...

Full description

Bibliographic Details
Main Authors: Rafael Meza, PhD, Jihyoun Jeon, PhD, MS, Evelyn Jimenez-Mendoza, MS, Yoonseo Mok, MPH, Pianpian Cao, PhD, MPH, Kristie L. Foley, PhD, MS, Caroline Chiles, MD, Jamie S. Ostroff, PhD, Paul M. Cinciripini, PhD, Jennifer Minnix, PhD, Nancy A. Rigotti, MD, Jennifer S. Haas, MD, Kathryn Taylor, PhD, Randi M. Williams, PhD, MPH, Benjamin A. Toll, PhD, Anne M. Joseph, MD, MPH
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:JTO Clinical and Research Reports
Subjects:
Smoking cessation
Lung cancer screening
Clinical trials
Trial participant characteristics
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364322000765

Internet

http://www.sciencedirect.com/science/article/pii/S2666364322000765

Similar Items